期刊文献+

Gut microbiome,liver immunology,and liver diseases 被引量:48

原文传递
导出
摘要 The gut microbiota is a complex and plastic consortium of microorganisms that are intricately connected with human physiology.The liver is a central immunological organ that is particularly enriched in innate immune cells and constantly exposed to circulating nutrients and endotoxins derived from the gut microbiota.The delicate interaction between the gut and liver prevents accidental immune activation against otherwise harmless antigens.Work on the interplay between the gut microbiota and liver has assisted in understanding the pathophysiology of various liver diseases.Of immense importance is the step from high-throughput sequencing(correlation)to mechanistic studies(causality)and therapeutic intervention.Here,we review the gut microbiota,liver immunology,and the interaction between the gut and liver.In addition,the impairment in the gut-liver axis found in various liver diseases is reviewed here,with an emphasis on alcohol-associated liver disease(ALD),nonalcoholic fatty liver disease(NAFLD),and autoimmune liver disease(AILD).On the basis of growing evidence from these preclinical studies,we propose that the gut-liver axis paves the way for targeted therapeutic modalities for liver diseases.
出处 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2021年第1期4-17,共14页 中国免疫学杂志(英文版)
基金 supported in part by the National Natural Science Foundation of China(grants#81830016,81771732,and 81620108002 to X.M.,#81922010 and 81873561 to R.T.) supported in part by services provided by the NIH centers P30 DK120515 and P50 AA011999 supported by the excellence initiative VASCage(Centre for Promoting Vascular Health in the Ageing Community) R8fD K-Centre(COMET program-Competence Centers for Excellent Technologies)funded by the Austrian Ministry for Transport,Innovation and Technology,the Austrian Ministry for Digital and Economic Affairs and the federal states Tyrol,Salzburg and Vienna.
  • 相关文献

参考文献6

二级参考文献16

  • 1Gyongyi Szabo,Shashi Bala.Alcoholic liver disease and the gut-liver axis[J].World Journal of Gastroenterology,2010,16(11):1321-1329. 被引量:54
  • 2DU Wei-Dong,ZHANG Yue-E,ZHAl Wei-Rong and ZHOU Xiao-Mei(Department of Pathology, Shanghai Medical University, Shanghai200032, China)(National Laboratory for Oncogenes and Related Genes, ShanghaiCencer Institute)See invited commentary on page 388.Dynamic changes of typeⅠ,Ⅲand N collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis[J].World Journal of Gastroenterology,1999,5(5):397-403. 被引量:47
  • 3Gourab Datta,Barry J Fuller,Brian R Davidson.Molecular mechanisms of liver ischemia reperfusion injury:Insights from transgenic knockout models[J].World Journal of Gastroenterology,2013,19(11):1683-1698. 被引量:51
  • 4Tsujimoto T,Kuriyama S,Yamazaki M,Nakatani Y,Okuda H,Yoshiji H,Fukui H.Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers[].International Journal of Oncology.2001
  • 5Ludwig J,Viggiano TR,McGill DB,Oh BJ.Nona-lcoholic steatohepatitis:Mayo Clinic experiences with a hitherto unnamed disease[].Mayo Clinic Proceedings.1980
  • 6D ay CP,James OF.Steatohepatitis: a tale of two "hits[].Gastroenterology.1998
  • 7Tomita K,Tamiya G,Ando S,Ohsumi K,Chiyo T,Mizutani A,Kitamura N,Toda K,Kaneko T,Horie Y,Han JY,Kato S,Shimoda M,Oike Y,Tomizawa M,Makino S,Ohkura T,Saito H,Kumagai N,Nagata H,Ishii H,Hibi T.Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice[].Gut.2006
  • 8Su GL.Lipopolysaccharides in liver injury: molecular mecha- nisms of Kupffer cell activation[].American Journal of Physiology Gastrointestinal and Liver Physiology.2002
  • 9Bugianesi E,Leone N,Vanni E,Marchesini G,Brunello F,Carucci P,Musso A,De Paolis P,Capussotti L,Salizzoni M,Rizzetto M.Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma[].Gastroenterology.2002
  • 10Sakaida,I,Kubota,M,Kayano,K,Takenaka,K,Mori,K,Okita,K.Prevention of fibrosis reduces enzyme-altered lesions in the rat liver[].Carcinogenesis.1994

共引文献145

同被引文献352

引证文献48

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部